Rhythm Pharmaceuticals, Inc.
RYTM
$96.22
-$1.70-1.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.55% | 64.99% | -3.98% | 1.10% | 30.92% |
| Total Depreciation and Amortization | -2.82% | -5.43% | -8.15% | -12.90% | -11.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 272.70% | -83.72% | 373.87% | -16.65% | -52.71% |
| Change in Net Operating Assets | 310.86% | -261.47% | 14.58% | 397.91% | 59.34% |
| Cash from Operations | 19.82% | 0.96% | 35.86% | 13.80% | 29.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 731.10% | -17.43% | -6.55% | 4.36% | -117.77% |
| Cash from Investing | 731.10% | -17.43% | -6.55% | 4.36% | -117.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 145.58% | 428.24% | 743.23% | -88.54% | 311.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -173.09% | -65.83% | -47.94% | -115.02% | 553.83% |
| Cash from Financing | -100.61% | 665.94% | 1,481.84% | -96.59% | 15,248.08% |
| Foreign Exchange rate Adjustments | 7.31% | 97.18% | 608.85% | -883.12% | -166.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -72.70% | 360.05% | 1,022.38% | -123.42% | 1,697.11% |